NONE OF THE NSW TRIALS HAVE STARTED YET ... HERE IS THE RESPONSE I GOT FROM NSW HEALTH
Thank you for your continued interest in the NSW Cannabis Clinical Trials Program.
The NSW Government has been working with the research groups to enable the commencement of these clinical trials.
The clinical trial for PALLIATIVE CARE has received ethics approval. The researchers are looking forward to commencing the trial as soon as regulatory approval from the Netherlands allows export of the standardised cannabis plant product that will be used in this trial.
The clinical trial for CHEMOTHERAPY INDUCED NAUSEA AND VOMITING has progressed to submission for ethics approval for the trial to commence. The researchers are working with the relevant Human Research Ethics Committee to expedite this process as much as possible.
The clinical trials program for PAEDIATRIC EPILEPSY is ** under development***. You may have recently seen that the Compassionate Access Scheme for children with epilepsy too severe to participate in clinical trials is underway, with patients being nominated by their treating neurologists for access. Protocols for the clinical trials using cannabividarin and Epidiolex® are also in development. A fact sheet regarding the compassionate access scheme is attached, for your information.
Your sincerely
Office of the Chief Health Officer
73 Miller Street, North Sydney, New South Wales 2060
Tel (02) 9391 9188 | ocho@doh.health.nsw.gov.au
73 Miller Street, North Sydney, New South Wales 2060
Tel (02) 9391 9188 | ocho@doh.health.nsw.gov.au
